Cargando…

Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019

INTRODUCTION: For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. METHODS: The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Yang, Wan-Li, Cai, Mei-Hong, Chen, Xiang, Zhao, Ran, Li, Meng-Ting, Yan, Xia-Lin, Xue, Li-Wei, Hong, Liu, Tang, Ming-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053627/
https://www.ncbi.nlm.nih.gov/pubmed/36978027
http://dx.doi.org/10.1186/s12889-023-15272-z
_version_ 1785015458400829440
author Li, Na
Yang, Wan-Li
Cai, Mei-Hong
Chen, Xiang
Zhao, Ran
Li, Meng-Ting
Yan, Xia-Lin
Xue, Li-Wei
Hong, Liu
Tang, Ming-Yu
author_facet Li, Na
Yang, Wan-Li
Cai, Mei-Hong
Chen, Xiang
Zhao, Ran
Li, Meng-Ting
Yan, Xia-Lin
Xue, Li-Wei
Hong, Liu
Tang, Ming-Yu
author_sort Li, Na
collection PubMed
description INTRODUCTION: For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. METHODS: The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. RESULTS: Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. CONCLUSION: GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15272-z.
format Online
Article
Text
id pubmed-10053627
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100536272023-03-30 Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019 Li, Na Yang, Wan-Li Cai, Mei-Hong Chen, Xiang Zhao, Ran Li, Meng-Ting Yan, Xia-Lin Xue, Li-Wei Hong, Liu Tang, Ming-Yu BMC Public Health Research INTRODUCTION: For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. METHODS: The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. RESULTS: Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. CONCLUSION: GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15272-z. BioMed Central 2023-03-29 /pmc/articles/PMC10053627/ /pubmed/36978027 http://dx.doi.org/10.1186/s12889-023-15272-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Na
Yang, Wan-Li
Cai, Mei-Hong
Chen, Xiang
Zhao, Ran
Li, Meng-Ting
Yan, Xia-Lin
Xue, Li-Wei
Hong, Liu
Tang, Ming-Yu
Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019
title Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019
title_full Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019
title_fullStr Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019
title_full_unstemmed Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019
title_short Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019
title_sort burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053627/
https://www.ncbi.nlm.nih.gov/pubmed/36978027
http://dx.doi.org/10.1186/s12889-023-15272-z
work_keys_str_mv AT lina burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT yangwanli burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT caimeihong burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT chenxiang burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT zhaoran burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT limengting burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT yanxialin burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT xueliwei burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT hongliu burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019
AT tangmingyu burdenofgastroesophagealrefluxdiseasein204countriesandterritories19902019asystematicanalysisfortheglobalburdenofdiseasestudy2019